Our Recommendations
- Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection (2016)
- Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring (2021)
- Updated Recommendations Onservice Delivery For The Treatment And Care Of People Living With HIV. Summary Slides (2021)
- Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring (2021)
New Publications
- Malawi Country Operational Plan 2021 Strategic Direction Summary May 19, 2021 (2021)
- Indicators and questions for monitoring progress on the 2021 Political Declaration on HIV and AIDS — Global AIDS Monitoring 2023 (2022)
- Lineamientos técnicos de consejería en ITS/VIH (2021)
- Update on the transition to dolutegravir-based antiretroviral therapy (2022)
- Updated Recommendations Onservice Delivery For The Treatment And Care Of People Living With HIV. Summary Slides (2021)
Filter
23
Featured
Recommendations
4
New Publications
7
Language
Document type
Guidelines
12
No document type
10
Studies & Reports
1
Countries / Regions
Malawi
2
Western and Central Europe
2
Kenya
1
El Salvador
1
Authors & Publishers
Publication Years
Category
HIV & STI
11
Policies & Guidelines HIV & TB
2
COVID-19
1
Toolboxes
This document defines the framework for Malawi’s National HIV Programs. Considering public health benefits and risks, as well as funding and resource implications, deviations from these guidelines are not supported by the Ministry of Health.
PEPFAR Malawi’s Country Operational Plan (COP) 2021 reflects a culmination of strong interagency collaboration between the PEPFAR Malawi team, Government of Malawi (GoM), and civil society organizations (CSOs) to mitigate the devastating impacts of COVID-19 and sustain progress achieved over the l...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
This technical report summarizes the discussions on the status of programmatic transition to tenofovir, lamivudine and dolutegravir (TLD) in low– and middle- income countries, addressing the best practices and major challenges faced by HIV programmes.
The latest data on safety and efficacy of do...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
En El Salvador, desde el surgimiento del primer caso de infección por Virus de Inmunodeficiencia Humana (VIH), la consejería de VIH se constituye en un recurso que favorece la prevención, encaminada a la identificación de factores de riesgo para ITS/VIH y otras Infecciones de Transmisión Sexual...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
July 2019
Policy brief
HIV Treatment
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment
Rutstein SE et al. Journal of the International AIDS Society 2017, 20:21579 http://www.jiasociety.org/index.php/jias/article/view/21579 | http://dx.doi.org/10.7448/IAS.20.1.21579
Октябрь 2017
Русский
Рекомендации EACS 9.0
HIV treatment
Policy brief
July 2017
WHO/HIV/2017.18
Guidelines
June 2017
HIV strategic information for impact
Version 9.0
Octobre 2017
